Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new Trulieve-branded medical marijuana dispensary through its affiliate, Chamounix Ventures, LLC. The dispensary at 1222 Arch St. is in the Center City section of Philadelphia . This location becomes the Company's 160th owned, operated or affiliated dispensary nationwide.
Located in the heart of Philadelphia , between City Hall and Reading Terminal Market, the dispensary will be open Monday – Saturday from 9am – 8pm and on Sunday from 10am – 6pm . Patients can choose from Trulieve's selection of premium whole flower products, including TruFlower and Cultivar Collection, as well as a wide range of vapes, tinctures, topicals and ingestibles.
"We are proud to begin the New Year by demonstrating our ongoing commitment to serving Pennsylvania's patient community through high quality and reliable medical marijuana products," said Kim Rivers , CEO of Trulieve. "We look forward to welcoming patients and strengthening community connections in this cornerstone market."
Additional Trulieve-affiliated dispensaries in Pennsylvania are located in Camp Hill , Cranberry Township , Devon , Harrisburg , Johnstown , King of Prussia , Pittsburgh , Reading , Scranton , Washington , Whitehall , York and Zelienople .
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .
Christine Hersey , Director of Investor Relations
+1 (424) 202-0210
Rob Kremer , Executive Director of Corporate Communications
+1 (404) 218-3077
View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-grand-opening-of-its-affiliates-chamounix-ventures-llc-philadelphia-dispensary-301456254.html
SOURCE Trulieve Cannabis Corp.